- Home
- TMDX vs LBTYA Comparison
TMDX vs LBTYA Comparison
Compare TMDX & LBTYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- LBTYA
- Stock Information
- Founded
- TMDX 1998
- LBTYA 2004
- Country
- TMDX United States
- LBTYA Bermuda
- Employees
- TMDX N/A
- LBTYA N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LBTYA Cable & Other Pay Television Services
- Sector
- TMDX Health Care
- LBTYA Telecommunications
- Exchange
- TMDX Nasdaq
- LBTYA Nasdaq
- Market Cap
- TMDX 4.0B
- LBTYA 3.8B
- IPO Year
- TMDX 2019
- LBTYA N/A
- Fundamental
- Price
- TMDX $124.89
- LBTYA $10.94
- Analyst Decision
- TMDX Buy
- LBTYA Buy
- Analyst Count
- TMDX 11
- LBTYA 5
- Target Price
- TMDX $130.73
- LBTYA $14.96
- AVG Volume (30 Days)
- TMDX 1.1M
- LBTYA 2.1M
- Earning Date
- TMDX 10-29-2025
- LBTYA 10-30-2025
- Dividend Yield
- TMDX N/A
- LBTYA N/A
- EPS Growth
- TMDX 170.70
- LBTYA N/A
- EPS
- TMDX 2.54
- LBTYA N/A
- Revenue
- TMDX $566,354,000.00
- LBTYA $4,770,600,000.00
- Revenue This Year
- TMDX $38.84
- LBTYA $13.20
- Revenue Next Year
- TMDX $20.46
- LBTYA $1.75
- P/E Ratio
- TMDX $48.26
- LBTYA N/A
- Revenue Growth
- TMDX 41.20
- LBTYA 170.50
- 52 Week Low
- TMDX $55.00
- LBTYA $9.03
- 52 Week High
- TMDX $145.50
- LBTYA $14.30
- Technical
- Relative Strength Index (RSI)
- TMDX 51.53
- LBTYA 47.88
- Support Level
- TMDX $115.21
- LBTYA $10.57
- Resistance Level
- TMDX $128.09
- LBTYA $11.01
- Average True Range (ATR)
- TMDX 7.97
- LBTYA 0.38
- MACD
- TMDX -0.88
- LBTYA 0.00
- Stochastic Oscillator
- TMDX 34.00
- LBTYA 54.12
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.